Evidence map›Paper›PMID 37118621›Full record

ReviewThe AAPS journal2023

Long-Acting Injectable Aqueous Suspensions-Summary From an AAPS Workshop.

René Holm, Robert W Lee, Joey Glassco, Nicholas DiFranco, Quanying Bao, Diane J Burgess, Viera Lukacova, Simone Alidori

Abstract readReview
PubMed Publisher
In one paragraph

Review in The AAPS journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. PLGA-based long-acting injectable (LAI) formulations.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

René HolmDepartment of Physics, Chemistry and Pharmacy, University of Southern Denmark, Campusvej 55, 5230, Odense M, Denmark. reho@sdu.dk.ORCID http://orcid.org/0000-0003-4894-7765
Robert W LeeLubrizol Life Science, Health, CDMO Division, 3894 Courtney St., Bethlehem, Pennsylvania, 18017, USA.
Joey GlasscoLubrizol Life Science, Health: 9911 Brecksville Road, Cleveland, Ohio, 44141, USA.
Nicholas DiFrancoLubrizol Life Science, Health: 9911 Brecksville Road, Cleveland, Ohio, 44141, USA.
Quanying BaoSchool of Pharmacy, University of Connecticut, Storrs, Connecticut, 06269, USA.
Diane J BurgessSchool of Pharmacy, University of Connecticut, Storrs, Connecticut, 06269, USA.
Viera LukacovaSimulations Plus, Inc., 42505 10Th Street, Lancaster, California, 93534, USA.
Simone AlidoriGlaxoSmithKline, 1250 S Collegeville Rd, Collegeville, Pennsylvania, 19426-2990, USA.

Funding

NHLBI NIH HHS HHSF223201710135C
6 · The paper itself

Abstract

Through many years of clinical application of long-acting injectables, there is clear proof that this type of formulation does not just provide the patient with convenience, but more importantly a more effective treatment of the medication provided. The formulation approach therefore contains huge untapped potential to improve the quality of life of many patients with a variety of different diseases. This review provides a summary of some of the central talks provided at the workshop with focus on aqueous suspensions and their use as a long-acting injectable. Elements as formulation, manufacturing, in vitro dissolution methods, in vitro and in vivo correlation, in silico modelling provide an insight into some of the current understandings, learnings, and not least gaps in the field.

Indexed as

Quality of LifeDelayed-Action PreparationsHumansInjectionsDelayed-Action Preparationsaqueous suspensionsin vitro dissolutionlong-acting injectablesmanufacturingPBPK modelling

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.